At EGB Ventures, we build and back companies that are transforming healthcare. From early-stage discoveries to clinical-stage development, these ventures are creating meaningful impact for patients, while delivering long-term value for investors
EGB Ventures is a family office dedicated to creating and developing innovative companies that advance clinical-stage pharmaceutical products. We form new ventures, recruit exceptional executives, and collaborate with other investors, scientists, and physicians worldwide to bring life-changing therapies to patients, while generating long-term value for investors.
We identify breakthrough science, build companies around it, and accelerate the development of therapies that can change lives.
We seek out compelling science with strong biological rationale, clinical relevance and clear differentiation. By partnering early with world-class researchers and leading institutions, we ensure our companies are built on rigorous, high-potential foundations supported by robust data.
We don't just invest - we create. We form new companies, recruit exceptional leadership talent, and provide hands-on strategic and operational guidance. Our team works closely with founders and scientific leaders to shape development strategy, guide clinical planning and ensure capital efficiency.
Our focus is on therapeutic areas where patients have limited or no effective treatment options. By prioritising innovative programs that target serious diseases with high unmet need, we aim to meaningfully improve patient outcomes and deliver long-term value for shareholders.
With leadership grounded in clinical medicine, we evaluate science through the lens of patient care. This ensures development decisions are driven by true clinical need, real-world treatment insight, and a deep understanding of patient and physician priorities.
We believe the most successful companies are built around meaningful patient benefit. Every program we support aims to significantly improve patient outcomes, from better efficacy and safety to enhanced quality of life and access to treatment.
Our team has founded, financed, and operated successful pharmaceutical ventures from pre-clinical stages through to late-stage clinical development and commercial partnerships. We know the path, and the pitfalls, and we bring that experience to every company we build.
We leverage a broad global ecosystem of scientists, clinical leaders, academia, investors and strategic partners. These connections enable access to breakthrough science, world-leading advisors, and high-quality capital to accelerate development at every stage.
